ALTERED IPSC-DERIVED NEURONS' SODIUM CHANNEL PROPERTIES IN SUBJECTS WITH MONGE'S DISEASE

被引:13
|
作者
Zhao, H. W. [1 ]
Gu, X. Q. [1 ]
Chailangkarn, T. [1 ,2 ]
Perkins, G. [4 ]
Callacondo, D. [1 ,5 ]
Appenzeller, O. [6 ]
Poulsen, O. [1 ]
Zhou, D. [1 ]
Muotri, A. R. [1 ,2 ,7 ]
Haddad, G. G. [1 ,3 ,7 ]
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA
[5] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Lima 36, Peru
[6] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM 87122 USA
[7] Rady Childrens Hosp, San Diego, CA 92123 USA
基金
美国国家卫生研究院;
关键词
chronic mountain sickness; induced pluripotent stem cells; neurons; Na+ channel; CHRONIC MOUNTAIN-SICKNESS; PLURIPOTENT STEM-CELLS; HIGH-ALTITUDE SICKNESS; TIBETAN CHINESE; MIGRAINE; ADULT; BRAIN; ACETAZOLAMIDE; ASSOCIATIONS; DEPRIVATION;
D O I
10.1016/j.neuroscience.2014.12.039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Monge's disease, also known as chronic mountain sickness (CMS), is a disease that potentially threatens more than 140 million highlanders during extended time living at high altitudes (over 2500 m). The prevalence of CMS in Andeans is about 15-20%, suggesting that the majority of highlanders (non-CMS) are rather healthy at high altitudes; however, CMS subjects experience severe hypoxemia, erythrocytosis and many neurologic manifestations including migraine, headache, mental fatigue, confusion, and memory loss. The underlying mechanisms of CMS neuropathology are not well understood and no ideal treatment is available to prevent or cure CMS, except for phlebotomy. In the current study, we reprogrammed fibroblast cells from both CMS and non-CMS subjects' skin biopsies into the induced pluripotent stem cells (iPSCs), then differentiated into neurons and compared their neuronal properties. We discovered that CMS neurons were much less excitable (higher rheobase) than non-CMS neurons. This decreased excitability was not caused by differences in passive neuronal properties, but instead by a significantly lowered Na+ channel current density and by a shift of the voltage-conductance curve in the depolarization direction. Our findings provide, for the first time, evidence of a neuronal abnormality in CMS subjects as compared to non-CMS subjects, hoping that such studies can pave the way to a better understanding of the neuropathology in CMS. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 50 条
  • [21] Isogenic iPSC-derived models of disease
    Emily Niemitz
    Nature Genetics, 2014, 46 (1) : 7 - 7
  • [22] Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
    Hedegaard, Anne
    Monzon-Sandoval, Jimena
    Newey, Sarah E.
    Whiteley, Emma S.
    Webber, Caleb
    Akerman, Colin J.
    STEM CELL REPORTS, 2020, 15 (01): : 38 - 51
  • [23] Modeling Alzheimer's disease with iPSC-derived brain cells
    Penney, Jay
    Ralvenius, William T.
    Tsai, Li-Huei
    MOLECULAR PSYCHIATRY, 2020, 25 (01) : 148 - 167
  • [24] Altered glutamate response and calcium dynamics in iPSC-derived striatal neurons from XDP patients
    Capetian, P.
    Stanslowsky, N.
    Bernhardi, E.
    Gruetz, K.
    Domingo, A.
    Brueggemann, N.
    Naujock, M.
    Seibler, P.
    Klein, C.
    Wegner, F.
    EXPERIMENTAL NEUROLOGY, 2018, 308 : 47 - 58
  • [25] Modeling Alzheimer’s disease with iPSC-derived brain cells
    Jay Penney
    William T. Ralvenius
    Li-Huei Tsai
    Molecular Psychiatry, 2020, 25 : 148 - 167
  • [26] Mitochondrial dysfunction in iPSC-derived Parkinson's disease astrocytes
    Fernandez-Carasa, I.
    Munoz, J. P.
    Pons, M.
    Beltramone, S.
    Calatayud, C.
    Carola, G.
    Soler-Vazquez, M. C.
    Richaud, Y.
    Tolosa, E.
    Herrero, L.
    Zorzano, A.
    Raya, A.
    Consiglio, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A124 - A124
  • [27] An Electrophysiological and Pharmacological Study of the Properties of Human iPSC-Derived Neurons for Drug Discovery
    Halliwell, Robert F.
    Salmanzadeh, Hamed
    Coyne, Leanne
    Cao, William S.
    CELLS, 2021, 10 (08)
  • [28] Human iPSC-derived midbrain dopaminergic neurons for disease modelling and cell therapy
    Kim, K. H.
    Mangan, K.
    Dickerson, S.
    Burke, T.
    Little, L.
    Chase, L.
    Carlson, C.
    McMahon, C.
    Berthet, P.
    Swanson, B.
    Jones, E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A49 - A49
  • [29] Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons
    Engle, Sandra J.
    Blaha, Laura
    Kleiman, Robin J.
    NEURON, 2018, 100 (04) : 783 - 797
  • [30] Aberrant iPSC-derived human astrocytes in Alzheimer's disease
    V C Jones
    R Atkinson-Dell
    A Verkhratsky
    L Mohamet
    Cell Death & Disease, 2017, 8 : e2696 - e2696